217 related articles for article (PubMed ID: 7634504)
21. Ten-year GH replacement increases bone mineral density in hypopituitary patients with adult onset GH deficiency.
Götherström G; Bengtsson BA; Bosaeus I; Johannsson G; Svensson J
Eur J Endocrinol; 2007 Jan; 156(1):55-64. PubMed ID: 17218726
[TBL] [Abstract][Full Text] [Related]
22. Elderly patients with adult-onset growth hormone deficiency are not osteopenic.
Toogood AA; Adams JE; O'Neill PA; Shalet SM
J Clin Endocrinol Metab; 1997 May; 82(5):1462-6. PubMed ID: 9141534
[TBL] [Abstract][Full Text] [Related]
23. Short and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone-deficient males.
Vandeweghe M; Taelman P; Kaufman JM
Clin Endocrinol (Oxf); 1993 Oct; 39(4):409-15. PubMed ID: 8287567
[TBL] [Abstract][Full Text] [Related]
24. Serum collagen crosslinks as markers of bone turn-over during GH replacement therapy in growth hormone deficient adults.
Rodríguez-Arnao J; James I; Jabbar A; Trainer PJ; Perrett D; Besser GM; Ross RJ
Clin Endocrinol (Oxf); 1998 Apr; 48(4):455-62. PubMed ID: 9640412
[TBL] [Abstract][Full Text] [Related]
25. Effects of 12-month GH treatment on bone metabolism and bone mineral density in adults with adult-onset GH deficiency.
Sartorio A; Ortolani S; Galbiati E; Conte G; Vangeli V; Arosio M; Porretti S; Faglia G
J Endocrinol Invest; 2001 Apr; 24(4):224-30. PubMed ID: 11383908
[TBL] [Abstract][Full Text] [Related]
26. Combined treatment of growth hormone and the bisphosphonate pamidronate, versus treatment with GH alone, in GH-deficient adults: the effects on renal phosphate handling, bone turnover and bone mineral mass.
Valk NK; Erdtsieck RJ; Algra D; Lamberts SW; Pols HA
Clin Endocrinol (Oxf); 1995 Sep; 43(3):317-24. PubMed ID: 7586601
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the optimum dose of growth hormone (GH) for restoring bone mass in adult-onset GH deficiency: results from two 12-month randomized studies.
Abrahamsen B; Hangaard J; Horn HC; Hansen TB; Gregersen G; Hansen-Nord M; Vahl N; Junker P; Andersen M; Hagen C
Clin Endocrinol (Oxf); 2002 Aug; 57(2):273-81. PubMed ID: 12153608
[TBL] [Abstract][Full Text] [Related]
28. Effects of up to 15 years of recombinant human GH (rhGH) replacement on bone metabolism in adults with growth hormone deficiency (GHD): the Leiden Cohort Study.
Appelman-Dijkstra NM; Claessen KM; Hamdy NA; Pereira AM; Biermasz NR
Clin Endocrinol (Oxf); 2014 Nov; 81(5):727-35. PubMed ID: 24816144
[TBL] [Abstract][Full Text] [Related]
29. Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency.
Johannsson G; Rosén T; Bosaeus I; Sjöström L; Bengtsson BA
J Clin Endocrinol Metab; 1996 Aug; 81(8):2865-73. PubMed ID: 8768843
[TBL] [Abstract][Full Text] [Related]
30. Effects of dietary treatment on bone mineral density in adults with celiac disease: factors predicting response.
Ciacci C; Maurelli L; Klain M; Savino G; Salvatore M; Mazzacca G; Cirillo M
Am J Gastroenterol; 1997 Jun; 92(6):992-6. PubMed ID: 9177517
[TBL] [Abstract][Full Text] [Related]
31. Long-term skeletal effects of recombinant human growth hormone (rhGH) alone and rhGH combined with alendronate in GH-deficient adults: a seven-year follow-up study.
Biermasz NR; Hamdy NA; Pereira AM; Romijn JA; Roelfsema F
Clin Endocrinol (Oxf); 2004 May; 60(5):568-75. PubMed ID: 15104559
[TBL] [Abstract][Full Text] [Related]
32. Prediction of bone mineral density of lumbar spine, hip, femoral neck and Ward's triangle by forearm bone mineral density.
Trivitayaratana W; Trivitayaratana P; Kongkiatikul S
J Med Assoc Thai; 2001 Mar; 84(3):390-6. PubMed ID: 11460941
[TBL] [Abstract][Full Text] [Related]
33. The impact of idiopathic childhood-onset growth hormone deficiency (GHD) on bone mass in subjects without adult GHD.
Lange M; Müller J; Svendsen OL; Kastrup KW; Juul A; Feldt-Rasmussen U
Clin Endocrinol (Oxf); 2005 Jan; 62(1):18-23. PubMed ID: 15638865
[TBL] [Abstract][Full Text] [Related]
34. Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset.
Kaufman JM; Taelman P; Vermeulen A; Vandeweghe M
J Clin Endocrinol Metab; 1992 Jan; 74(1):118-23. PubMed ID: 1727808
[TBL] [Abstract][Full Text] [Related]
35. Effects on bone mass after eight years of hormonal replacement therapy.
Eiken P; Nielsen SP; Kolthoff N
Br J Obstet Gynaecol; 1997 Jun; 104(6):702-7. PubMed ID: 9197874
[TBL] [Abstract][Full Text] [Related]
36. Reduced bone mineral density in adults with growth hormone (GH) deficiency: increased bone turnover during 12 months of GH substitution therapy.
Degerblad M; Bengtsson BA; Bramnert M; Johnell O; Manhem P; Rosén T; Thorén M
Eur J Endocrinol; 1995 Aug; 133(2):180-8. PubMed ID: 7655642
[TBL] [Abstract][Full Text] [Related]
37. Growth hormone replacement in adults and bone mineral density: a systematic review and meta-analysis.
Davidson P; Milne R; Chase D; Cooper C
Clin Endocrinol (Oxf); 2004 Jan; 60(1):92-8. PubMed ID: 14678294
[TBL] [Abstract][Full Text] [Related]
38. The effect of growth hormone replacement therapy in hypopituitary adults on calcium and bone metabolism.
Beshyah SA; Thomas E; Kyd P; Sharp P; Fairney A; Johnston DG
Clin Endocrinol (Oxf); 1994 Mar; 40(3):383-91. PubMed ID: 8187303
[TBL] [Abstract][Full Text] [Related]
39. [The effect of growth hormone replacement therapy on markers of bone formation and bone mineral density in elderly men].
Kozakowski J; Papierska L; Krassowski J; Zgliczyński S
Pol Arch Med Wewn; 1998 Oct; 100(4):306-12. PubMed ID: 10335039
[TBL] [Abstract][Full Text] [Related]
40. The effects of growth hormone replacement therapy on bone metabolism in adult-onset growth hormone deficiency: a 2-year open randomized controlled multicenter trial.
Bex M; Abs R; Maiter D; Beckers A; Lamberigts G; Bouillon R
J Bone Miner Res; 2002 Jun; 17(6):1081-94. PubMed ID: 12054164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
